Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
31/03/2026 07:00
Mar 31 (Reuters) - Allergy Therapeutics H1 gross profit GBP 21.479 million. H1 EBIT GBP -11.375 million H1 net income GBP -19.918 million
Recent news on Allergy Therapeutics
See all newsBrief: Allergy Therapeutics Expects FY 2026 Revenue Of £59.90 Million, Up 9% Reported
UK's Allergy Therapeutics FY revenue beats on Grassmuno launch
Allergy Therapeutics - Trading update for the year ended 30 June 2026
Brief: Allergy Therapeutics Appoints Helge Weiner-Trapness As Executive Chairman
Allergy Therapeutics - Appointment of Executive Chairman